Kaye Edward M. MD sold STOK
August 29, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 1,029 shares of Stoke Therapeutics, Inc. at $20.00 per share, a transaction worth $20.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,029
Price
$20.00
Total value
$20.6K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 29, 2025
Filing dateSeptember 3, 2025
Shares owned after152,441
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.